Skip to content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Wednesday, December 10, 2025
World Today News
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Copyright 2021 - All Right Reserved
Home » CMPNY » Page 19
Tag:

CMPNY

Technology

AMD signs AI chip-supply deal with OpenAI, shares surge over 34%

by Rachel Kim – Technology Editor October 7, 2025
written by Rachel Kim – Technology Editor

AMD ‌Secures ‌AI Chip Supply Deal⁢ with OpenAI,Stock Jumps Over​ 34%

SAN FRANCISCO,Feb 29 – Advanced micro Devices ⁣(AMD) shares surged ‌more than 34% in extended trading Thursday after the company announced a‌ multi-billion‍ dollar ‍deal to ⁢supply artificial intelligence (AI) chips to⁣ OpenAI,the ⁤creator of chatgpt. ‍The agreement positions AMD as a key hardware⁤ partner for the leading AI developer and signals growing demand for chips ‍beyond​ Nvidia ‍in the rapidly expanding AI market.

The partnership ⁣addresses a critical bottleneck in the AI boom: the availability of ​specialized⁤ hardware. OpenAI, like many⁤ AI companies, relies on powerful⁤ processors to train and run its large language models. While Nvidia currently dominates this ⁣space, diversifying the supply⁤ chain is crucial for fostering competition ⁤and ensuring‍ the continued growth‍ of AI​ technologies. This deal is expected to significantly⁢ boost AMD’s ‌revenue and market share in the AI sector, ‍challenging Nvidia’s current ‌stronghold.

AMD will provide‌ its Instinct ​MI300 series of data center GPUs ⁤to ‌power OpenAI’s workloads. The ​agreement includes a commitment from ⁢OpenAI to utilize AMD’s ⁤chips for years to come, providing AMD with a stable revenue stream and a platform​ to showcase its AI capabilities.

“This is a important​ win ⁤for AMD, validating ‍their⁤ investment in the Instinct line and establishing ‌them as a serious​ contender in the AI chip​ market,”‍ said Stacy Rasgon, a semiconductor analyst at Bernstein. “The deal​ demonstrates‍ that OpenAI ‍is willing to work with ​multiple vendors, which is ​a positive sign for the industry as a⁤ whole.”

The financial terms ‍of⁣ the deal ⁣were not disclosed, but AMD indicated it expects⁤ to begin recognizing revenue from the partnership ⁤in the second quarter of 2024.⁣ The company anticipates the deal will⁣ contribute meaningfully to its data center revenue growth​ in the coming years.

AMD’s stock closed at $167.89 on Thursday and was trading at $225.80 in ⁤after-hours trading as of 6:30 PM EST.

October 7, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Exclusive: Novo Nordisk cuts hit production line jobs at key US plant, posts show

by Dr. Michael Lee – Health Editor October 7, 2025
written by Dr. Michael Lee – Health Editor

Novo ‍Nordisk ⁤has reduced staffing on a production line⁣ at it’s chartwell, north Carolina, manufacturing plant, internal postings show, impacting jobs as ⁣the pharmaceutical giant navigates supply constraints for its blockbuster weight-loss drug, Wegovy, and diabetes medication, Ozempic. The cuts, revealed in workforce postings dated May 10, ⁤affect positions related to a pen injector ‍assembly line, according to the documents.

The job reductions come as Novo Nordisk struggles ⁢to meet soaring demand for its GLP-1 receptor agonists, leading to ongoing supply limitations and rationing for patients. While Novo nordisk has invested heavily in expanding manufacturing capacity, including at the Chartwell facility, these ⁢recent cuts suggest‍ immediate adjustments are being made to align production⁤ with current output. The ​company has not disclosed the exact number of positions eliminated, but postings indicate roles⁤ were removed across multiple shifts.

Internal postings detail ​the elimination of “Pen Assembly Operators” and “Technicians” on the line, with some ‍employees being offered option roles within the plant.⁢ One posting states the company is “restructuring” the⁢ line to “optimize ⁤efficiency.” Novo Nordisk⁣ confirmed ​the changes in ‍a statement, stating the company is “continuously evaluating‌ and adjusting its operations to best meet patient needs and ensure long-term sustainability.”

The Chartwell plant is a‌ critical facility for Novo Nordisk’s US operations,responsible for the final stages of ‌filling and packaging its injectable drugs. The company has been working to increase capacity at ⁣the site, announcing ⁣a $2.3 ‍billion investment in 2023 ⁢to expand production. ⁢Though, scaling ​up manufacturing for⁢ complex biologics like Wegovy and Ozempic takes time, and the company ⁣has repeatedly cautioned that supply will remain tight throughout much of 2024.

Demand for Wegovy, in particular, has outstripped supply since its launch in June ⁣2022, fueled by ⁢growing awareness of its efficacy in weight management and widespread social media attention. The drug’s limited availability has frustrated patients and healthcare providers, prompting calls for increased production and alternative treatment⁣ options. Novo ‍Nordisk anticipates increased capacity ⁤from expansions at both Chartwell and other facilities later this year, but the ​immediate impact ⁣of the production line adjustments remains unclear.

October 7, 2025 0 comments
0 FacebookTwitterPinterestEmail
Business

Adani Raises $112.6M in Debt Through Private Bond Placement

by Priya Shah – Business Editor October 7, 2025
written by Priya Shah – Business Editor

Adani Enterprises is ⁢tapping the debt market ‍with a private placement,​ marking its return ⁤to fundraising through this route‍ after a two-year hiatus, bankers familiar with the ⁢matter told reuters.

The move comes ​as ​the conglomerate⁢ seeks to bolster its financial resources for ongoing projects and potential expansion, ‌following a period of market volatility sparked ⁢by a critical report earlier this year.The private placement will allow Adani Enterprises to raise capital from a select ⁢group of investors, providing a quicker and more discreet funding option than⁤ a public ⁤offering. This fundraising‌ effort signals renewed‌ investor confidence and provides Adani Enterprises with flexibility as it navigates a dynamic economic landscape and pursues growth opportunities across its diverse portfolio of businesses, including ⁣infrastructure, energy, and airports.

October 7, 2025 0 comments
0 FacebookTwitterPinterestEmail
World

Nationalist Sanae Takaichi set to be Japan’s first female premier

by Lucas Fernandez – World Editor October 4, 2025
written by Lucas Fernandez – World Editor

Nationalist Sanae Takaichi is poised to⁣ become Japan‘s first female prime minister after winning the ‍first round of the Liberal democratic Party (LDP) leadership ⁣election on⁢ Wednesday, September 29, 2021. ⁤Takaichi, a conservative known for her right-wing views and⁣ close ties to the Unification Church, secured a run-off against vaccination⁣ minister Taro Kono.‌ The winner of the September 29 vote will almost certainly become the next prime minister‌ due ⁣to the LDP’s majority in the lower house of parliament.

Takaichi’s potential premiership marks a meaningful shift for ‌Japan, a nation lagging behind other developed countries in female political depiction. Her victory comes as Japan grapples with an aging population, economic stagnation, and growing ‌security concerns in the region. The outcome of the LDP leadership race will shape Japan’s economic ‍policies, its approach to social issues, and its foreign policy direction, particularly regarding relations ⁢with China and the United States.

The first round saw Takaichi garner ⁣86​ votes, exceeding expectations and forcing a head-to-head contest with Kono, who received 65 votes. Former ⁣foreign minister Fumio Kishida was eliminated after ⁣securing 56 votes. The final vote, including ballots​ from LDP members and local party officials,​ is ‌scheduled for September 29.

takaichi has campaigned on a platform of⁤ economic revitalization through deregulation and a revision ⁤of the pacifist constitution, a long-held goal of the LDP’s conservative wing. She has also expressed a desire to strengthen Japan’s defence capabilities and deepen⁢ its alliance with the United States.

“I want to create a Japan where women can⁢ shine,” Takaichi said during a recent campaign speech, emphasizing‌ her⁤ commitment ⁤to​ addressing gender inequality. However, her ties to the Unification Church have drawn criticism ⁣from opponents and raised concerns​ about potential conflicts of interest.

October 4, 2025 0 comments
0 FacebookTwitterPinterestEmail
Technology

Scores of Bollywood AI videos vanish from YouTube after Reuters story

by Rachel Kim – Technology Editor October 3, 2025
written by Rachel Kim – Technology Editor

Bollywood AI Videos Disappear From YouTube Following Reuters Investigation

New Delhi – Scores of deepfake videos featuring‍ Bollywood stars have been removed from YouTube after a Reuters story highlighted the proliferation of AI-generated content exploiting the likenesses of Indian actors without their consent. The takedowns began shortly after Reuters‌ published its findings on February 29, 2024, revealing a ⁢surge in unauthorized AI videos on the platform.

The removal of these videos underscores growing concerns about the misuse of artificial⁣ intelligence and the lack of robust safeguards to protect individuals ⁢from digital impersonation. The issue⁣ is especially acute in ​India’s prolific⁣ film industry, where celebrity images​ are widely circulated and easily exploited. the ⁢videos, often sexually suggestive or ​depicting fabricated endorsements, raised alarm among actors and industry stakeholders, prompting calls for stricter regulations and platform accountability.

Reuters identified ​at ‍least 83 deepfake videos featuring prominent Bollywood actors,⁢ garnering ⁤millions of views before being flagged for removal.‍ The videos utilized AI technology ⁤to convincingly portray actors in scenarios they never participated in, raising legal and ethical ⁢questions about consent, defamation, and ​intellectual property ⁢rights.

Aditya Kalra,Company News Editor for Reuters ‌in India,led the reporting,focusing on the business coverage and strategies of major ‌companies impacted by the issue. Arpan Chaturvedi,a Reuters correspondent based in New Delhi,contributed ⁤to the coverage⁤ by reporting on the legal ramifications and​ court cases ‍related to⁣ the unauthorized use of celebrity likenesses.

YouTube confirmed⁢ to Reuters that it removed ‌the videos⁤ for violating ⁤its policies prohibiting the creation ‌of misleading or deceptive content. The platform stated it is continuously⁣ refining its detection systems and working with industry partners to ⁤address the ⁣evolving threat of deepfakes. though, ⁤experts ⁣warn ⁢that the rapid advancement of AI‍ technology ⁢necessitates⁢ a more proactive and extensive approach to⁢ combat the⁣ spread of unauthorized AI-generated content.

October 3, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

FDA Approves Jazz Pharma and Roche Combination Therapy for Lung Cancer

by Dr. Michael Lee – Health Editor October 3, 2025
written by Dr. Michael Lee – Health Editor

Jazz Pharmaceuticals PLC​ said on Monday the U.S. Food ‍and Drug Governance approved Roche’s combination therapy of Tecentriq (atezolizumab) and⁢ Zybrestat (fosdenopterin) for adults with advanced non-small cell lung cancer whose tumors have EGFR exon 20 insertion ⁢mutations. The approval marks a significant advancement for⁢ patients with this specific,historically difficult-to-treat form‍ of lung cancer,offering a ⁤new targeted treatment option.

Approximately 5-10% ⁤of patients with non-small cell lung cancer harbor⁢ EGFR ‍exon‍ 20 ​insertion mutations. These mutations drive cancer growth but are ​not addressed by existing EGFR inhibitors. The ‌approval of the Tecentriq and​ Zybrestat combination, ⁣following a priority review, provides ⁣a much-needed therapy for this ⁢patient population, perhaps extending lives and‍ improving quality of​ life. The therapy’s approval‌ is based on ​data from​ the phase 3 MARIPOSA trial,⁤ which demonstrated a statistically significant ⁢enhancement in progression-free survival ​compared to chemotherapy.

The FDA granted ‍the combination therapy Breakthrough Therapy designation, Priority​ review, ⁢and Orphan Drug designation.The recommended dosage of Tecentriq⁣ is 1200 mg administered intravenously every three ​weeks, in combination with‍ Zybrestat, taken orally twice‍ daily. Jazz ⁢will co-promote the therapy with ‌Roche in the United States.

October 3, 2025 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Search:

Recent Posts

  • 15‑Year‑Old Beats Snapchat Age Check Ahead of Australia’s Social Media Ban

    December 9, 2025
  • Storm Bram Rail Disruptions Across Scotland, England and Wales – Evening Commute Update

    December 9, 2025
  • Miami Mayoral Runoff 2024: Democrats Target Republican Stronghold

    December 9, 2025
  • Kremlin Praises Trump’s National Security Strategy, Ukraine Peace Talks Stall

    December 7, 2025
  • Yipirinya School Crisis: Principal Guilty, Staff Redundancies Loom

    December 7, 2025

Follow Me

Follow Me
  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com


Back To Top
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com